Smoking selects mutants

In the October 24 Proceedings of the National Academy of Sciences Rodin and Rodin propose that smoking leads to increased lung cancer not by causing more mutations, but by selecting for those mutations that do arise (Proc Natl Acad Sci USA 2000, 97:12244-12249). They take advantage of an increase in p53 mutational data in nonsmokers and find, for example, that the frequency of silent mutations in p53 is identical between smokers and non-smokers. In contrast, twice as many lung cancers from smoke

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the October 24 Proceedings of the National Academy of Sciences Rodin and Rodin propose that smoking leads to increased lung cancer not by causing more mutations, but by selecting for those mutations that do arise (Proc Natl Acad Sci USA 2000, 97:12244-12249). They take advantage of an increase in p53 mutational data in nonsmokers and find, for example, that the frequency of silent mutations in p53 is identical between smokers and non-smokers. In contrast, twice as many lung cancers from smokers have a defective p53 as compared to lung cancers from non-smokers. Rodin and Rodin suggest that the more often that smoking-related stresses such as hypoxia induce p53-related cell cycle arrest or apoptosis, the higher the probability that a p53 mutant cell will be selected. If true, this would mean that eliminating specific carcinogens from cigarettes would have little effect on the occurrence of lung cancer.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform